Evidence map›Paper›PMID 23531597›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2013

Streptococcal collagen-like protein A and general stress protein 24 are immunomodulating virulence factors of group A Streptococcus.

James A Tsatsaronis, Andrew Hollands, Jason N Cole, Peter G Maamary, Christine M Gillen, Nouri L Ben Zakour, Malak Kotb, Victor Nizet, Scott A Beatson, Mark J Walker and 1 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

James A TsatsaronisIllawarra Health and Medical Research Institute, and School of Biological Sciences, University of Wollongong, Wollongong, NSW, 2522, Australia.
Andrew Hollands
Jason N Cole
Peter G Maamary
Christine M Gillen
Nouri L Ben Zakour
Malak Kotb
Victor Nizet
Scott A Beatson
Mark J Walker
Martina L Sanderson-Smith
University of Queensland · AUUniversity of California, San Diego · USIllawarra Health and Medical Research Institute · AUUniversity of Cincinnati · USUniversity of Wollongong · AU

Funding

GAS Switch from Colonizing Bacterium to Invasive PathogenR01AI077780 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR · 2008 to 2019
$3.8M
NIAID NIH HHS R01 AI077780
6 · The paper itself

Abstract

In Western countries, invasive infections caused by M1T1 serotype group A Streptococcus (GAS) are epidemiologically linked to mutations in the control of virulence regulatory 2-component operon (covRS). In indigenous communities and developing countries, severe GAS disease is associated with genetically diverse non-M1T1 GAS serotypes. Hypervirulent M1T1 covRS mutant strains arise through selection by human polymorphonuclear cells for increased expression of GAS virulence factors such as the DNase Sda1, which promotes neutrophil resistance. The GAS bacteremia isolate NS88.2 (emm 98.1) is a covS mutant that exhibits a hypervirulent phenotype and neutrophil resistance yet lacks the phage-encoded Sda1. Here, we have employed a comprehensive systems biology (genomic, transcriptomic, and proteomic) approach to identify NS88.2 virulence determinants that enhance neutrophil resistance in the non-M1T1 GAS genetic background. Using this approach, we have identified streptococcal collagen-like protein A and general stress protein 24 proteins as NS88.2 determinants that contribute to survival in whole blood and neutrophil resistance in non-M1T1 GAS. This study has revealed new factors that contribute to GAS pathogenicity that may play important roles in resisting innate immune defenses and the development of human invasive infections.

Indexed as

AnimalsBacterial AdhesionBacterial ProteinsCell LineElectrophoresis, Gel, Two-DimensionalGene Expression ProfilingGene Expression Regulation, BacterialGenome, BacterialGenomicsHost-Pathogen InteractionsHumansMiceMicrobial ViabilityMutationNeutrophil ActivationNeutrophilsBacterial Proteinsgls24 protein, Streptococcus pyrogenesProteomeStreptococcal collagen-like protein A, Streptococcus pyrogenesinnate immunitynext-generation sequencingsystems biology

Identifiers

PMID23531597
PMCPMC4050422
OpenAlexW2163402349

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.